X
Breast Tumours: WHO Classification of Tumours
Breast Tumours: WHO Classification of Tumours

Breast Tumours: WHO Classification of Tumours (Medicine)

Product ID : 42256953
4.9 out of 5 stars


Galleon Product ID 42256953
Shipping Weight 2.38 lbs
I think this is wrong?
Model
Manufacturer World Health Organization
Shipping Dimension 10.47 x 8.31 x 0.83 inches
I think this is wrong?
-
Save 28%
Before ₱ 16,751
12,099

*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
  • Electrical items MAY be 110 volts.
  • 7 Day Return Policy
  • All products are genuine and original
  • Cash On Delivery/Cash Upon Pickup Available

Pay with

Breast Tumours: WHO Classification of Tumours Features

  • brand: World Health Organization

  • WHO Classification of Breast Tumours: WHO Classification of Tumours, Volume 2 (World Health Organization classification of tumours)


About Breast Tumours: WHO Classification Of Tumours

****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Breast Tumours is the second volume in the 5th edition of the WHO series on the classification of human tumors. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumors and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. This book will be of special interest to pathologists, oncologists, surgeons and epidemiologists who manage or research breast tumors. Sections are included on all recognized neoplasms of the breast including the nipple and areola. Since the previous edition there have been changes based on recent molecular and genetic information, with impact on clinical practice.